| Revision as of 08:28, 1 June 2004 editNunh-huh (talk | contribs)30,738 editsNo edit summary← Previous edit | Revision as of 16:41, 28 June 2004 edit undo150.148.0.28 (talk)No edit summaryNext edit → | ||
| Line 22: | Line 22: | ||
| * '']'' | * '']'' | ||
| * '']'' | * '']'' | ||
| * '']'' | |||
| == Other == | == Other == | ||
Revision as of 16:41, 28 June 2004
Levofloxacin is relatively new fluoroquinolone antibiotic, marketed by Ortho-McNeil under the brand name Levaquin. Chemically, Levaquin is the S-enantiomer (L-isomer) of ofloxacin. Levofloxacin is effective against a number of gram-positive and gram-negative bacteria.
Gram-positive bacteria
- Enterococcus faecalis (many strains are only moderately susceptible)
- Staphylococcus aureus (methicillin-susceptible strains)
- Staphylococcus epidermidis (methicillin-susceptible strains)
- Staphylococcus saprophyticus
- Streptococcus pneumoniae (including penicillin-resistant strains*)
- Streptococcus pyogenes
Gram-negative bacteria
- Enterobacter cloacae
- Klebsiella pneumoniae
- Pseudomonas aeruginosa
- Escherichia coli
- Legionella pneumophila
- Serratia marcescens
- Haemophilus influenzae
- Moraxella catarrhalis
- Haemophilus parainfluenzae
- Proteus mirabilis
- Campylobacter
Other
Some information extracted from Levaquin Prescribing information.
This article is a stub. You can help Misplaced Pages by expanding it. |